Medical Advocates
Nitazoxanide (HIV and HCV Indications)
 
Main Page

New and Noteworthy
Journal Data
 





 
ARV Investigational  Drugs Main New/Noteworthy Home Page      
Last Update:  March 11, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
 
March 2012
 
  • POSTER
    Nitazoxanide Reduces HIV Replication in vitro and Elicits Strong Antiviral Acquired and Innate Immune Responses
    M Clerici , D Trabatton , M Pace ,  et al     19 CROI
         PDF Poster     Abstract
  • POSTER
         Augmentation of Interferon Signaling by Nitazoxanide: A Therapeutic Strategy For HIV/HCV-co-infected
    Relapsers to Pegylated Interferon + Ribavirin Therapy
    A  Osinusi C Wang, X Zhang, et al
         (19 CROI)
    PDF Poster         Abstract
Journal Abstracts, Papers, and Commentaries
 
  No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.
 Laufer N, Abusamra L, Bolcic F, et al
 Antiviral Res. 2011 Dec;92(3):497-9.
 Abstract
 
A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.
Kabil SM, Soliman MS, Youssef SM, Mounier BI.
 J Egypt Soc Parasitol. 2011 Aug;41(2):251-61.
Abstract

Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.
Yon C, Viswanathan P, Rossignol JF, Korba B.
 Antiviral Res. 2011 Sep;91(3):233-40
Abstract

The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.
 Elazar M, Liu M, McKenna SA,
 Gastroenterology. 2009 Nov;137(5):1827-35.
 Abstract

Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.
Rossignol JF, Elfert A, El-Gohary Y, Keeffe EB.
 Gastroenterology. 2009 Mar;136(3):856-62.
Abstract
 
FULLTEXT ARTICLE
Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.
Korba BE, Elazar M, Lui P,
Antimicrob Agents Chemother. 2008 Nov;52(11):4069-71
Paper
 
Conference Reports, Abstracts, and Posters
 


 
ARV Investigational  Drugs Main New/Noteworthy Home Page      

Nitazoxanid